Daniel Dautan
2dneuro.bsky.social
Daniel Dautan
@2dneuro.bsky.social
Senior Postdoc Karolinska Institute Sweden.
In Vivo electrophysiology Depression and Parkinson. Love acetylcholine and dopamine .
Founder and CEO of 2DNeuro an affordable approach of wireless optogenetic, DBS and animal tracking metabolism.
September 16, 2025 at 4:22 PM
April 28, 2025 at 2:14 PM
Thanks a lot for the highlight. Regarding wireless devices for taVNS in humans, there are some companies and 2DNEURO that might work on something in the future, but they are focusing on preclinical. We are happy that our technology is advancing the research for life threatening conditions
March 4, 2025 at 7:57 AM
This is an approach already done in animals and humans. That shows results in inflammation, depression and even neurodegenerative disorder. Experiments in animals were limited due to wired connection. My company made a fully wireless implant that shows similar results and helps in our understanding
January 29, 2025 at 2:24 PM
There are already available taVNS implant for patients that looks like headphone and work tremendously.
January 29, 2025 at 1:20 PM
The implant is very small that might be why. Trying to develop the best implants. Here it is battery less. We can target superficial or deep structures in the animals home cage or in apparatus.
January 29, 2025 at 1:05 PM
What do you mean?
January 29, 2025 at 12:54 PM
The small implant on the head of the mice is a wireless device to stimulate the brain projection to the ear. Relevant for inflammation, depression as well as neurodegenerative disorder. We are the first to offer that wireless device to study its role in these diseases.
January 29, 2025 at 12:53 PM